Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Rifomycin S
2. Rifampicin S
Molecular Weight | 822.9 g/mol |
---|---|
Molecular Formula | C43H58N4O12 |
XLogP3 | 4 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 5 |
Exact Mass | 822.40512330 g/mol |
Monoisotopic Mass | 822.40512330 g/mol |
Topological Polar Surface Area | 217 A^2 |
Heavy Atom Count | 59 |
Formal Charge | 0 |
Complexity | 1750 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 4 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 6 | |
---|---|
Drug Name | Rifadin |
PubMed Health | Rifampin (Injection) |
Drug Classes | Antitubercular |
Drug Label | RIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin |
Active Ingredient | Rifampin |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 150mg; 300mg; 600mg/vial |
Market Status | Prescription |
Company | Sanofi Aventis Us |
2 of 6 | |
---|---|
Drug Name | Rifampin |
Active Ingredient | Rifampin |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 150mg; 300mg; 600mg/vial |
Market Status | Prescription |
Company | Bedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts |
3 of 6 | |
---|---|
Drug Name | Rimactane |
PubMed Health | Rifampin |
Drug Classes | Antitubercular |
Drug Label | Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i... |
Active Ingredient | Rifampin |
Dosage Form | Capsule |
Route | Oral |
Strength | 300mg |
Market Status | Prescription |
Company | Prosam Labs |
4 of 6 | |
---|---|
Drug Name | Rifadin |
PubMed Health | Rifampin (Injection) |
Drug Classes | Antitubercular |
Drug Label | RIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin |
Active Ingredient | Rifampin |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 150mg; 300mg; 600mg/vial |
Market Status | Prescription |
Company | Sanofi Aventis Us |
5 of 6 | |
---|---|
Drug Name | Rifampin |
Active Ingredient | Rifampin |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 150mg; 300mg; 600mg/vial |
Market Status | Prescription |
Company | Bedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts |
6 of 6 | |
---|---|
Drug Name | Rimactane |
PubMed Health | Rifampin |
Drug Classes | Antitubercular |
Drug Label | Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i... |
Active Ingredient | Rifampin |
Dosage Form | Capsule |
Route | Oral |
Strength | 300mg |
Market Status | Prescription |
Company | Prosam Labs |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 75-64-9
End Use API : Rifampicin
About The Company : Capital Farma offers a comprehensive range of pharmaceutical solutions. Our API offering includes active ingredients sourced exclusively from top European manuf...
1-Amino-1-cyclopentylpiperazine
CAS Number : 61379-64-4
End Use API : Rifampicin
About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...
CAS Number : 6928-85-4
End Use API : Rifampicin
About The Company : Huvepharma® Italia is a fast-growing global pharmaceutical company duly organized for developing, manufacturing and marketing advanced intermediates and active...
CAS Number : 6928-85-4
End Use API : Rifampicin
About The Company : SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) for Pharmaceutical, Cosmetic and Fine Chemical Industry....
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
22 May 2025
Reply
28 Jun 2024
Reply
25 Jun 2024
Reply
01 Nov 2023
Reply
27 Sep 2023
Reply
28 Jul 2023
Reply
09 May 2023
Reply
05 Oct 2022
Reply
04 Jan 2022
Reply
14 May 2024
Reply
18 Oct 2023
Reply
21 Oct 2022
Reply
20 Sep 2021
Reply
10 Sep 2021
Reply
17 Aug 2021
Reply
12 Apr 2021
Reply
04 Sep 2018
Reply
17 Aug 2018
REF. STANDARDS & IMPURITIES
CAS Number : 17555-51-0
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0012.10
Rifampin Quinone (25 mg) (1,4-dideoxy-1,4- di...
CAS Number : 13983-13-6
Quantity Per Vial : 25
Sale Unit : mg
Price : $775.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1604202 / R109W 0
CAS Number : 13292-46-1
Quantity Per Vial : 300
Sale Unit : mg
Price : $245.00
Details : Material Origin- Fermentation- Chemical Synth...
Monograph :
Storage :
Code/Batch No : Catalog #1604009 / R124W 0
CAS Number : 125833-03-6
Quantity Per Vial : 25
Sale Unit : mg
Price : $630.00
Details : Material Origin- Fermentation- Chemical Synth...
Monograph :
Storage :
Code/Batch No : Catalog #1604199 / F120C0
ABOUT THIS PAGE
98
PharmaCompass offers a list of Rifampin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rifampin manufacturer or Rifampin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rifampin manufacturer or Rifampin supplier.
PharmaCompass also assists you with knowing the Rifampin API Price utilized in the formulation of products. Rifampin API Price is not always fixed or binding as the Rifampin Price is obtained through a variety of data sources. The Rifampin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rofact manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rofact, including repackagers and relabelers. The FDA regulates Rofact manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rofact API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rofact manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rofact supplier is an individual or a company that provides Rofact active pharmaceutical ingredient (API) or Rofact finished formulations upon request. The Rofact suppliers may include Rofact API manufacturers, exporters, distributors and traders.
click here to find a list of Rofact suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rofact DMF (Drug Master File) is a document detailing the whole manufacturing process of Rofact active pharmaceutical ingredient (API) in detail. Different forms of Rofact DMFs exist exist since differing nations have different regulations, such as Rofact USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rofact DMF submitted to regulatory agencies in the US is known as a USDMF. Rofact USDMF includes data on Rofact's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rofact USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rofact suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Rofact Drug Master File in Japan (Rofact JDMF) empowers Rofact API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Rofact JDMF during the approval evaluation for pharmaceutical products. At the time of Rofact JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Rofact suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rofact Drug Master File in Korea (Rofact KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rofact. The MFDS reviews the Rofact KDMF as part of the drug registration process and uses the information provided in the Rofact KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rofact KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rofact API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rofact suppliers with KDMF on PharmaCompass.
A Rofact CEP of the European Pharmacopoeia monograph is often referred to as a Rofact Certificate of Suitability (COS). The purpose of a Rofact CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rofact EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rofact to their clients by showing that a Rofact CEP has been issued for it. The manufacturer submits a Rofact CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rofact CEP holder for the record. Additionally, the data presented in the Rofact CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rofact DMF.
A Rofact CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rofact CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rofact suppliers with CEP (COS) on PharmaCompass.
A Rofact written confirmation (Rofact WC) is an official document issued by a regulatory agency to a Rofact manufacturer, verifying that the manufacturing facility of a Rofact active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rofact APIs or Rofact finished pharmaceutical products to another nation, regulatory agencies frequently require a Rofact WC (written confirmation) as part of the regulatory process.
click here to find a list of Rofact suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rofact as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rofact API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rofact as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rofact and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rofact NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rofact suppliers with NDC on PharmaCompass.
Rofact Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rofact GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rofact GMP manufacturer or Rofact GMP API supplier for your needs.
A Rofact CoA (Certificate of Analysis) is a formal document that attests to Rofact's compliance with Rofact specifications and serves as a tool for batch-level quality control.
Rofact CoA mostly includes findings from lab analyses of a specific batch. For each Rofact CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rofact may be tested according to a variety of international standards, such as European Pharmacopoeia (Rofact EP), Rofact JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rofact USP).